The CEO of Novo Nordisk took questions for more than two hours during a Senate Health Committee hearing focused on addressing ...
Lawmakers say the drug company has made $50 billion on the sales of those two drugs since 2018. Tuesday, members of the U.S.
Sen. Bernie Sanders questions Novo Nordisk CEO Lars Jorgensen in a hearing on Capitol Hill about the high prices Americans pay for Ozempic and Wegovy compared with people in other countries.